Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

Talking Therapeutics

Taking the “Ouch” Out of Gout Attacks in Heart Failure

05/26/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

Dr Jennings discusses new research on colchicine for gout flares and reminds fellow pharmacists to keep in mind appropriate dosing and potential drug interactions.

Dr Jennings discusses new...

05/26/2022

Pharmacy Learning Network

Talking Therapeutics

End of 2022 Wrap Up: SGLT2 Inhibitors, COVID-19 Treatments and Boosters

12/28/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In his final column of the year, Dr Jennings revisits the most pertinent stories from 2022, emphasizing the efficacy of SGLT2 inhibitors for patients with heart failure as well as the continuously changing landscape of COVID-19 treatments.

In his final column of the year,...

12/28/2022

Pharmacy Learning Network

Talking Therapeutics

Is Medical Cannabis Hard on the Heart?

02/05/2024

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this installment of Talking Therapeutics, Dr Jennings discusses a new study that aimed to address this gap in the literature concerning the cardiovascular safety of medical cannabis use.

In this installment of Talking...

02/05/2024

Pharmacy Learning Network

Talking Therapeutics

Anticoagulation Reversal for DOAC-related Intracranial Hemorrhage

06/23/2021

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this week’s issue of Talking Therapeutics, Dr Jennings discusses the findings of a recently published meta-analysis that explored outcomes of patients with intracranial hemorrhage managed with various DOAC reversal agents.

In this week’s issue of Talking...

06/23/2021

Pharmacy Learning Network

Talking Therapeutics

Super Statins Benefits Extend to Young and Old Alike

12/15/2021

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this week's installment of Talking Therapeutics, Dr Jennings reviews recent findings and highlights health and cost benefits of prescribing statins to both young and older adults.

In this week's installment of...

12/15/2021

Pharmacy Learning Network

Talking Therapeutics

Tackling Monkeypox With Tecovirimat

08/11/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

Dr Jennings covers the basics of tecovirimat, an agent available for compassionate use in patients with monkeypox.

Dr Jennings covers the basics of...

08/11/2022

Pharmacy Learning Network

Talking Therapeutics

Time to Drop Aspirin for Long-term Antiplatelet Therapy?

06/01/2023

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

Dr Jennings explores the efficacy and safety of using aspirin or a P2Y12 receptor antagonist in patients with drug-eluting stents.

Dr Jennings explores the...

06/01/2023

Pharmacy Learning Network

Talking Therapeutics

Cutting Through Cost Barriers for Heart Failure Medications

03/02/2023

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.

In the latest installment of...

03/02/2023

Pharmacy Learning Network

Talking Therapeutics

Less Is Certainly More: The Frontier of Weight Loss Pharmacotherapy

07/14/2021

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In this week’s issue of Talking Therapeutics, Dr Jennings explores the latest data surrounding a promising new agent for weight loss.

In this week’s issue of Talking...

07/14/2021

Pharmacy Learning Network

Talking Therapeutics

Pause on Surgery for Prosthetic Valve Thrombosis

03/10/2022

Douglas L. Jennings , PharmD, FACC, FAHA, FCCP, FHFSA, BCPS;

In the newest installment of Talking Therapeutics, Dr Jennings reviews new data comparing surgery to thrombolytic therapy for prosthetic valve thrombosis and predicts where the future of care may be headed.

In the newest installment of...

03/10/2022

Pharmacy Learning Network